BIOLINERX
Careers | Contact Us
search

Press Releases
February 12, 2014
BL-8040 study published in Molecular Cancer Therapeutics

BL-8040 currently undergoing Phase 2 trial for acute myeloid leukemia (AML), and expected to commence Phase 1 trial in stem cell mobilization in Q2 2014; top-line results from both trials expected in Q4 2014
January 23, 2014
BL-8040 previously received Orphan Drug Designation for treatment of Acute Myeloid Leukemia
BL-8040 expected to commence Phase 1 trial in stem cell mobilization in Q2 2014; top-line results expected in H2 2014

January 21, 2014
CE Mark registration trial for BL-5010P expected to begin H1 2014; results expected H2 2014

January 13, 2014
Phase 1 Trial of BL-8040 expected to begin in Q2 2014; top-line results expected in H2 2014
BL-8040 is also in Phase 2 for AML; top-line results expected in H2 2014
January 8, 2014
JHL Biotech to develop and commercialize BL-9020 in China and additional 
Southeast Asia countries
December 18, 2013
Results of Phase 1/2 trial for BL-7010 expected in mid-2014
171-180  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next